Elanix Biotechnologies AG Logo

Elanix Biotechnologies AG

ELN | F

Overview

Corporate Details

ISIN(s):
DE000A0WMJQ4
LEI:
391200SYNFFL0NPAJK90
Country:
Germany
Address:
Hanauer Landstrasse 291, 60314 Frankfurt am Main
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2012 as a spin-off from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Epalinges, Switzerland with offices in Hamburg and listed on the Frankfurt stock exchange under the symbol ELN.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Elanix Biotechnologies AG and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-02-14 10:05
Board/Management Information
Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
English 5.1 KB
2022-12-21 18:30
Major Shareholding Notification
German 4.6 KB
2022-12-19 12:30
Declaration of Voting Results & Voting Rights Announcements
German 14.0 KB
2022-12-06 13:00
Declaration of Voting Results & Voting Rights Announcements
German 14.2 KB
2022-12-05 10:15
Declaration of Voting Results & Voting Rights Announcements
German 13.7 KB
2022-12-02 15:15
Declaration of Voting Results & Voting Rights Announcements
German 14.0 KB
2020-02-27 12:19
Board/Management Information
ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD …
English 4.8 KB
2019-10-03 10:34
Report Publication Announcement
English 2.0 KB
2019-08-21 16:49
Report Publication Announcement
English 2.0 KB
2019-08-19 16:58
Report Publication Announcement
English 2.0 KB
2019-07-26 13:51
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB
2019-07-23 16:59
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB
2019-07-22 10:17
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB
2019-06-25 14:03
Declaration of Voting Results & Voting Rights Announcements
English 13.9 KB
2019-06-25 13:57
Major Shareholding Notification
English 13.9 KB

Automate Your Workflow. Get a real-time feed of all Elanix Biotechnologies AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Elanix Biotechnologies AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions for pharma licensing.
France ALNFL
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
Nortem BioGroup Logo
Biotech R&D of natural products for consumer health, home, and animal nutrition.
Spain MLBIO
NRGene Technologies Ltd. Logo
AI genomics software accelerating plant & animal breeding for the agriculture industry.
Israel NRGN
NUFORMIX PLC Logo
A pharma firm repurposing drugs for fibrosis and oncology via proprietary cocrystal technology.
United Kingdom NFX
Nykode Therapeutics ASA Logo
Developing targeted immunotherapies and vaccines for cancer and infectious diseases.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive drugs for sight-threatening eye diseases.
Switzerland OCS
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC
ONCODESIGN Logo
Develops precision cancer therapies and diagnostics targeting resistance and metastasis.
France ALONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.